Bruce Booth

Co-Founder at Nimbus Therapeutics LLC

Bruce Booth

Bruce Booth

Co-Founder at Nimbus Therapeutics LLC

Overview
Career Highlights

Nimbus Therapeutics LLC
Viridian Therapeutics, Inc.
Rodin Therapeutics, Inc.

RelSci Relationships

5364

Primary Location

Wellesley Hills, MA

Number of Boards

30

Birthday

1974

Age

47

Relationships
RelSci Relationships are individuals Bruce Booth likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Chairman at Synlogic, Inc.

Relationship likelihood: Strong

Co-Founder at Translate Bio, Inc.

Relationship likelihood: Strong

Advisor, Executive Chairman, Disc Therapeutics at Atlas Venture, Inc.

Relationship likelihood: Strong

Director, Chief Executive Officer & President at Schrödinger, Inc.

Relationship likelihood: Strong

General Partner at Lilly Ventures Management Co. LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Navitor Pharmaceuticals, Inc.

Relationship likelihood: Strong

Co-Founder & Chief Executive Officer at Spero Therapeutics, Inc.

Relationship likelihood: Strong

Investor & Board Member at Skillz, Inc.

Relationship likelihood: Strong

Co-Founder at Maiden Lane Ventures LLC

Relationship likelihood: Strong

Chief Financial Officer at Atlas Venture, Inc.

Relationship likelihood: Strong

Paths to Bruce Booth
Potential Connections via
Relationship Science
You
Bruce Booth
Co-Founder at Nimbus Therapeutics LLC
Education
Doctorate in Molecular Immunology

Oxford is a collegiate university, consisting of the central University and colleges. The central University is composed of academic departments and research centres, administrative departments, libraries and museums. The 38 colleges are self-governing and financially independent institutions, which are related to the central University in a federal system. There are also six permanent private halls, which were founded by different Christian denominations and which still retain their Christian character.

Bachelor of Science in Biochemistry, summa cum laude

Penn State is a multicampus public research university that educates students from Pennsylvania, the nation and the world, and improves the well being and health of individuals and communities through integrated programs of teaching, research, and service. Penn State, founded in 1855 as an agricultural college, admitted its first class in 1859. Today Penn State is one of four “state-related” universities (along with the University of Pittsburgh, Temple University, and Lincoln University), institutions that are not state-owned and -operated but that have the character of public universities and receive substantial state appropriations.

Memberships
Member
Current

Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY.

Career History
Partner
2011 - Current

Atlas Venture is seeks investment opportunities in companies located in the US. The firm target companies operating in the fields of life sciences & technology and biotech. They provides financing for early stage capital requirements.

Co-Founder
Current

Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA.

Partner
Tenure Unconfirmed

Atlas Venture Advisors, Inc. operates as a venture capital firm. The company is headquartered in Boston, MA.

Boards & Committees
Director
2005 - Current
Member, Board of Directors
Current

Atlas Venture is seeks investment opportunities in companies located in the US. The firm target companies operating in the fields of life sciences & technology and biotech. They provides financing for early stage capital requirements.

Director
Current

Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA.

Member, Board of Trustees
Prior

The New York Academy of Medicine advances the health of people in cities. An independent organization since 1847, NYAM addresses the health challenges facing the world’s urban populations through interdisciplinary approaches to policy leadership, innovative research, evaluation, education, and community engagement. Drawing on the expertise of its professional staff, diverse partners worldwide and more than 2,000 elected Fellows from across the professions, its current priorities are to create environments in cities that support healthy aging; to strengthen systems that prevent disease and promote the public’s health; to eliminate health disparities; and to preserve and promote the heritage of medicine and public health.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$5,000 - $10K
2012

The New York Academy of Medicine advances the health of people in cities. An independent organization since 1847, NYAM addresses the health challenges facing the world’s urban populations through interdisciplinary approaches to policy leadership, innovative research, evaluation, education, and community engagement. Drawing on the expertise of its professional staff, diverse partners worldwide and more than 2,000 elected Fellows from across the professions, its current priorities are to create environments in cities that support healthy aging; to strengthen systems that prevent disease and promote the public’s health; to eliminate health disparities; and to preserve and promote the heritage of medicine and public health.

$5,000 - $10K
2011

The New York Academy of Medicine advances the health of people in cities. An independent organization since 1847, NYAM addresses the health challenges facing the world’s urban populations through interdisciplinary approaches to policy leadership, innovative research, evaluation, education, and community engagement. Drawing on the expertise of its professional staff, diverse partners worldwide and more than 2,000 elected Fellows from across the professions, its current priorities are to create environments in cities that support healthy aging; to strengthen systems that prevent disease and promote the public’s health; to eliminate health disparities; and to preserve and promote the heritage of medicine and public health.

$1 - $499
2010

The New York Academy of Medicine advances the health of people in cities. An independent organization since 1847, NYAM addresses the health challenges facing the world’s urban populations through interdisciplinary approaches to policy leadership, innovative research, evaluation, education, and community engagement. Drawing on the expertise of its professional staff, diverse partners worldwide and more than 2,000 elected Fellows from across the professions, its current priorities are to create environments in cities that support healthy aging; to strengthen systems that prevent disease and promote the public’s health; to eliminate health disparities; and to preserve and promote the heritage of medicine and public health.

Transactions
Details Hidden

Alkermes, Inc., Alkermes Plc purchase Rodin Therapeutics, Inc. from Johnson & Johnson Innovation JJDC, Inc., Atlas Venture, Inc., Hatteras Venture Partners, Third Point Ventures LLC, Google Ventures, Remeditex Ventures LLC

Details Hidden

miRagen Therapeutics, Inc. (Inactive) raised money in a private placement transaction

Details Hidden

miRagen Therapeutics, Inc. (Inactive) raised money in a private placement transaction

Investments
Details Hidden

Kymera Therapeutics, Inc. operates as a biotechnology company, which engages in curing untreatable diseases. It focuses on discovering and developing novel small molecule therapeutics. The firm's proprietary integrated degradation platform consists of informatics-driven target identification, novel E3 ligases and ligands, proprietary predictive modeling, and novel degradation tools. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.

Details Hidden

Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA.

Details Hidden

miRagen Therapeutics, Inc. develops microRNA-based therapeutics for cardiovascular and muscle diseases. It leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance RNA-based technologies and potential drug candidates for its own pipeline and in strategic collaborations. The firm aso focuses on hematological malignancies, fibrosis and neuro inflammation. The company was founded by William S. Marshall, Michael R. Bristow, Marvin H. Caruthers, Bruce Lee Booth and Eric Newell Olson in 2007 and is headquartered in Boulder, CO.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Bruce Booth. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Bruce Booth's profile does not indicate a business or promotional relationship of any kind between RelSci and Bruce Booth.